$153.11
00.00%
Pre-Market: 7:32 PM EDT
Comments
Loading...
Latest news for Johnson & Johnson (NYSE:JNJ) Stock
Johnson & Johnson Stock (NYSE: JNJ)
Categories: All
Wednesday, November 20, 2024
Monday, November 18, 2024
Friday, November 15, 2024
Thursday, November 14, 2024
Wednesday, November 13, 2024
Monday, November 11, 2024
Friday, November 08, 2024
Thursday, November 07, 2024
Wednesday, November 06, 2024
Monday, October 28, 2024
- Global Psychedelic Drugs Market Expected To Reach $10.2B By 2028 Amid Growing Mental Health Crises
- Google To Launch New "Sexual Health & Wellnes...
- Johnson & Johnson's Tremfya Seeks Expanded Use Approval After It Shares Encouraging Late-Stage Study Data In Crohn's Disease
- Johnson & Johnson Announced Results From Phas...
Friday, October 25, 2024
Thursday, October 24, 2024
Wednesday, October 23, 2024
Tuesday, October 22, 2024
Monday, October 21, 2024
Friday, October 18, 2024
Thursday, October 17, 2024
Wednesday, October 16, 2024
- Citigroup Maintains Buy on Johnson & Johnson,...
- Johnson & Johnson's MedTech Challenges Loom Amid Chinese Market Pressures And Orthopedics Overhaul, Analysts Say
- Wells Fargo Maintains Equal-Weight on Johnson...
- Cantor Fitzgerald Reiterates Overweight on Jo...
- RBC Capital Maintains Outperform on Johnson &...
- Morgan Stanley Maintains Equal-Weight on John...
- Reported Earlier, Johnson & Johnson Ordered T...
Tuesday, October 15, 2024
- J&Js Talc Powder Is Responsible For Connectic...
- Cancer Drugs Propel J&J Beyond Wall Street Estimates
- Nasdaq Down 150 Points; Johnson & Johnson Reports Better-Than-Expected Q3 Results
- Chipmaker Stocks Sink On ASML Earnings Leak, Oil Eyes Worst 1-Day Drop This Year, Small Caps Rally: What's Driving Markets Tuesday?
- Google Goes Nuclear For AI Power, Israeli Restraint Impacts Stocks, Gold, And Oil
- J&J Executive Says Monitoring Potential Impac...
- Johnson & Johnson's Q3 Earnings: Revenue And EPS Beat On Strong Cancer Drug Sales, Revises Annual Outlook To Reflect V-Wave Acquisition
- Nipocalimab Shows Sustained Disease Control I...
- Wall Street On Edge As Nasdaq Nears Record High, Oil Prices Plummet: Strategist Says There's Opportunity If Resilience Continues
- Johnson & Johnson shares are trading higher a...
- Johnson & Johnson Expects 2024 Adjusted EPS O...